Experimental investigations suggest that modulation of NNMT activity may influence cellular pathways associated with energy utilization, nutrient partitioning, and metabolic adaptation
Realistic Expectation Setting: While AOD-9604 enhances metabolic function and fat oxidation, it is not a standalone solution for body composition change
CS10 (Cagrilintide 5 mg + Semaglutide 5 mg) Dual GLP1 / Amylin agonist
It decreases inflammatory cytokines TNF-alpha, IL-1beta, IL-6, and NF-kappaB
Reported benefits (per available research): FDA-approved, clinical-trial-supported reduction of excess visceral abdominal fat in HIV-associated lipodystrophy, the only indication with robust human RCT evidence behind it Studied in a randomized, placebo-controlled trial for possible support of executive function and cognitive performance in healthy older adults and adults with mild cognitive impairment (Baker et al., 2012) Proposed, but far less rigorously studied in healthy or bodybuilding populations, to support lean body mass and body composition changes through GH/IGF-1 axis stimulation
Stallion is open to men and women (18+) for most treatments